business
Surprise drugs boost for Johnson & Johnson
Three months ago, Johnson & Johnson (J&J) predicted an ugly 2019 as the healthcare giant faced thousands of consumer lawsuits and pressure in the US on drug prices.
Person: Vamil Divan
A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC
